Login
From:
Neuromyelitis News
(Uncensored)
subscribe
NMOSD candidate therapy BAT4406F depletes B-cells, eases disability
https://neuromyelitisnews.com/news/nmosd-candidate-therapy-bat4406f-depletes-b-cells-eases-disability/
links
backlinks
Tagged with:
b-cells
nmosd
A Phase 1 clinical study tested the therapy in 15 patients positive for antibodies against AQP4, those most commonly associated with NMOSD.
Roast topics
Find topics
Roast it!
Roast topics
Find topics
Find it!
Roast topics
Find topics
Find it!
